Welcome to our dedicated page for 5E Advanced Materials SEC filings (Ticker: FEAM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading a pre-revenue miner’s filings can feel like panning for gold in pages of geology reports. 5E Advanced Materials’ latest 10-K tops 200 pages and folds resource estimates, permitting risks, and vertical-integration plans into dense legal language. If you have ever searched for “5E Advanced Materials SEC filings explained simply,” you know the challenge.
Stock Titan solves the problem. Our AI scans every 5E Advanced Materials quarterly earnings report 10-Q filing, flags changes in cash burn, and surfaces drill-hole updates—all before the coffee cools. You’ll receive real-time alerts the moment 5E Advanced Materials Form 4 insider transactions real-time hit EDGAR, plus concise summaries that make understanding 5E Advanced Materials SEC documents with AI effortless. Whether you track “5E Advanced Materials insider trading Form 4 transactions” or need a 5E Advanced Materials annual report 10-K simplified, the platform delivers.
What insights can you uncover?
- 5E Advanced Materials 8-K material events explained—from resource upgrades to offtake agreements.
- 5E Advanced Materials executive stock transactions Form 4—see which directors buy shares before pivotal drilling results.
- 5E Advanced Materials proxy statement executive compensation—quickly compare incentive structures to production milestones.
- 5E Advanced Materials earnings report filing analysis—spot shifts in capital spending and project timelines quarter over quarter.
Every document, every update, analysed in context. No more combing through appendices—our platform turns technical disclosures into actionable intelligence so you can focus on what matters: deciding if FEAM’s boron and lithium ambitions align with your portfolio.
Form 4 filing overview – 5E Advanced Materials, Inc. (FEAM)
Director Bryn Llywelyn Jones reported a series of restricted stock unit (RSU) settlements and related tax-withholding sales on 1 July 2025. The filing captures three RSU grants that all vested on the same date:
- 2,063 shares from a 21 Jan 2025 grant
- 3,578 shares from a 31 Mar 2025 grant
- 5,316 shares from a new 30 Jun 2025 grant
For each vesting event, the insider used transaction code “F” to dispose of shares at $3.55 per share to cover withholding taxes, selling a total of 4,055 shares. After these transactions, Jones’ direct beneficial ownership increased from zero to 6,902 common shares.
The share amounts have been adjusted for the 1-for-23 reverse split enacted on 14 Feb 2025, indicating that all figures are on a post-split basis. No derivative securities remain outstanding for the insider after settlement, suggesting full conversion of the reported RSUs.
Investment take-away: The filing reflects routine equity compensation activity rather than an open-market purchase or discretionary sale. Net share accumulation aligns the director’s interests with shareholders, while the limited sale appears solely tax-related. Market impact is therefore expected to be minimal.
Form 4 filing overview – 5E Advanced Materials, Inc. (FEAM)
Director Bryn Llywelyn Jones reported a series of restricted stock unit (RSU) settlements and related tax-withholding sales on 1 July 2025. The filing captures three RSU grants that all vested on the same date:
- 2,063 shares from a 21 Jan 2025 grant
- 3,578 shares from a 31 Mar 2025 grant
- 5,316 shares from a new 30 Jun 2025 grant
For each vesting event, the insider used transaction code “F” to dispose of shares at $3.55 per share to cover withholding taxes, selling a total of 4,055 shares. After these transactions, Jones’ direct beneficial ownership increased from zero to 6,902 common shares.
The share amounts have been adjusted for the 1-for-23 reverse split enacted on 14 Feb 2025, indicating that all figures are on a post-split basis. No derivative securities remain outstanding for the insider after settlement, suggesting full conversion of the reported RSUs.
Investment take-away: The filing reflects routine equity compensation activity rather than an open-market purchase or discretionary sale. Net share accumulation aligns the director’s interests with shareholders, while the limited sale appears solely tax-related. Market impact is therefore expected to be minimal.
DSS, Inc. (NYSE American: DSS) disclosed in an 8-K filed on July 1, 2025 that it dismissed Grassi & Co., CPAs, P.C. as its independent registered public accounting firm, effective June 27, 2025. The Board of Directors approved the decision and, on the same date, appointed HTL International, LLC as the new auditor.
The company states that, for the engagement period from July 1, 2022 through June 27, 2025, there were no disagreements with Grassi concerning accounting principles, financial-statement disclosures, or audit scope and procedures that would have required reference in Grassi’s reports. DSS also confirms that, during the last two fiscal years and up to the engagement date, it did not consult HTL on any accounting matters or the type of audit opinion to be rendered, and there were no reportable events under Item 304(a)(1)(v) of Regulation S-K.
Exhibit 16.1 will contain Grassi’s letter to the SEC confirming the disclosures. The change suggests a routine auditor transition rather than a reaction to a dispute, but investors may monitor the first audit cycle for any adjustments or restatements under the new firm.
DSS, Inc. (NYSE American: DSS) disclosed in an 8-K filed on July 1, 2025 that it dismissed Grassi & Co., CPAs, P.C. as its independent registered public accounting firm, effective June 27, 2025. The Board of Directors approved the decision and, on the same date, appointed HTL International, LLC as the new auditor.
The company states that, for the engagement period from July 1, 2022 through June 27, 2025, there were no disagreements with Grassi concerning accounting principles, financial-statement disclosures, or audit scope and procedures that would have required reference in Grassi’s reports. DSS also confirms that, during the last two fiscal years and up to the engagement date, it did not consult HTL on any accounting matters or the type of audit opinion to be rendered, and there were no reportable events under Item 304(a)(1)(v) of Regulation S-K.
Exhibit 16.1 will contain Grassi’s letter to the SEC confirming the disclosures. The change suggests a routine auditor transition rather than a reaction to a dispute, but investors may monitor the first audit cycle for any adjustments or restatements under the new firm.
Streamline Health Solutions, Inc. (Nasdaq: STRM) has filed a preliminary Schedule 14A seeking stockholder approval for its $5.34-per-share all-cash merger with Mist Holding Co., the parent of MDaudit. At closing, Merger Sub will merge into Streamline, which will become a wholly-owned subsidiary of MDaudit and cease to be publicly traded.
Key economic terms
- Cash consideration of $5.34 per share, representing a 138 % premium to the 5/28/25 close and 117 % to the 30-day VWAP.
- No financing contingency; Parent states it has sufficient cash on hand to fund the deal and related costs.
- Options and warrants with exercise prices below $5.34 will be cashed-out; all currently outstanding options and warrants are “out-of-the-money” and will be cancelled for no consideration.
- Termination fee payable by Streamline to Parent is $950 K; no reverse termination fee disclosed.
Governance & process
- The Streamline Board unanimously approved the merger, deemed it fair, and recommends voting “FOR” all proposals.
- Cain Brothers rendered a fairness opinion to the Board on 5/28/25.
- Certain directors and officers entered into Voting & Support Agreements, committing their shares to support the transaction (exact percentage not yet specified).
- Completion requires the affirmative vote of at least 66 2/3 % of outstanding shares. Failure to vote counts as an “AGAINST.”
Timeline & conditions
- Special Meeting will be held virtually on a date to be set; record date also to be set.
- Expected closing is Q3 2025, subject to stockholder approval and customary conditions (no financing or regulatory conditions highlighted).
- Outside date for termination is 12/31/25.
Post-closing the STRM shares will be delisted from Nasdaq and deregistered under the Exchange Act. Stockholders who properly perfect appraisal rights under Delaware law may seek a court-determined “fair value” instead of the $5.34 cash payment.